CLM Form 4: Director Matthew Morris Sells 26,193 Shares at $8.18
Matthew Morris, a director of Cornerstone Strategic Investment Fund, Inc. (CLM), reported a sale of common stock on 09/10/2025.
Rhea-AI Filing Summary
Matthew Morris, a director of Cornerstone Strategic Investment Fund, Inc. (CLM), reported a sale of common stock on 09/10/2025. The Form 4 shows a disposition of 26,193.113 shares at a price of $8.1827 per share, leaving the reporting person with the stated post-transaction beneficial ownership of 26,193.113 shares (reported as a direct holding). The filing is signed on 09/11/2025. No derivative transactions or additional explanatory details are provided in the report.
Positive
- None.
Negative
- Director disposed of 26,193.113 shares on 09/10/2025 at $8.1827 per share, indicating insider selling activity
- No Rule 10b5-1 plan or explanatory details are disclosed in the Form 4, limiting context for the sale
Insights
TL;DR: Director sold shares; single reported sale with no derivatives or plan disclosed.
The filing indicates a straightforward open-market disposition of 26,193.113 shares by a director at $8.1827 per share. From a governance perspective, a director sale can reflect routine liquidity needs rather than a change in company outlook; however, absence of any Rule 10b5-1 plan disclosure in the form means the sale is not explicitly characterized as pre-planned. The report contains only basic information: transaction date, price, quantity and direct ownership, with no additional context on continuing holdings or intentions. This limits conclusions about motive or future insider behavior.
TL;DR: Insider sale of ~26.2k shares at $8.18 is material to monitor but lacks context for valuation impact.
Reported disposal of 26,193.113 shares at $8.1827 is a clear insider selling event. Without company-level metrics (total outstanding shares, percentage ownership before/after) in the filing, it is not possible to assess the sale's significance relative to overall float or to draw valuation conclusions. The absence of derivative activity or multiple transactions suggests a single non-derivative sale on 09/10/2025. Investors seeking material impact should compare this sale to the director's total holdings disclosed elsewhere and to recent market activity in CLM.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 0.7152 | $8.1827 | $5.85 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Matthew Morris report for CLM on the Form 4?
What is Matthew Morris's relationship to CLM?
Does the Form 4 show any derivative transactions or exercise activity?
When was the Form 4 signed and filed?
Is there information indicating the sale was part of a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.